Drug Information
Drug Generic Name | VENLAFAXINE HYDROCHLORIDE |
Drug Class | SELECTIVE SEROTONINE AND NOREPINPHRINE REUPTAKE INHIBITORS (SNRI) |
Chapter | Central Nervous System |
This is a serotonin, and noradrenaline reuptake inhibitor (SNRI); it lacks the sedative and antimuscarinic effects of the tricyclic antidepressants. Indications: depressive illness. Cautions: may cause blood pressure increase; hepatic or renal impairment; close supervision of patients with high risk of suicidal tendencies during initial treatment; cardiac disease; history of mania. Should not be withdrawn immediately. Contra-indications: conditions associated with high risk of cardiac arrhythmia, uncontrolled hypertension; pregnancy and breast-feeding; severe renal and hepatic impairment. Side Effects: nausea, anorexia; sexual dysfunction; insomnia, nervousness, abnormal dreams; hypertension, palpitation; visual disturbances. Dose: initially 75 mg daily in 2 divided doses increased if necessary after several weeks to 150 mg daily in 2 divided doses. Severly depressed or hospitalized patients, initially 150 mg daily in 2 divided doses increased if necessary in steps of up to 75 mg every 2-3 days to max. 375 mg daily then gradually reduced. |
|
Brand Name |
|